Modalis Therapeutics Corp
TSE:4883
Modalis Therapeutics Corp
Revenue
Modalis Therapeutics Corp
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Modalis Therapeutics Corp
TSE:4883
|
Revenue
¥0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
GNI Group Ltd
TSE:2160
|
Revenue
¥26B
|
CAGR 3-Years
39%
|
CAGR 5-Years
39%
|
CAGR 10-Years
64%
|
|
PeptiDream Inc
TSE:4587
|
Revenue
¥28.7B
|
CAGR 3-Years
35%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Takara Bio Inc
TSE:4974
|
Revenue
¥47.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
J
|
Japan Tissue Engineering Co Ltd
TSE:7774
|
Revenue
¥2.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
11%
|
S
|
StemRIM Inc
TSE:4599
|
Revenue
¥2.4B
|
CAGR 3-Years
4%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
See Also
What is Modalis Therapeutics Corp's Revenue?
Revenue
0
JPY
Based on the financial report for Dec 31, 2023, Modalis Therapeutics Corp's Revenue amounts to 0 JPY.